Zydus’ US subsidiary acquires speciality drug asset in US March 8, 2022 Auto Bot News 0 Under the terms of the agreement, Sentynl will acquire global rights to Nulibry and will be responsible for the ongoing development and commercialisation of Nulibry in the US.